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Correspondence 131encountered the terms bgobbledygookQ and bpoppycock.Q
Nevertheless, the monograph does not integrate scientific
knowledge with a histopathologic diagnostic paradigm that
accurately reflects the totality of atypical melanocytic lesions
encountered by dermatopathologists.—John T. Seykora,
MD, PhD, Department of Dermatology, University of
Pennsylvania Medical School, Philadelphia, PACorrespondence case of squamoid maturation. Cervical carcinomas containedLetter to the editor:of reserve cell keratins in a CIN lesion indicates its potential
To the Editor,
We read the paper by Carrilho et al [1] with great
interest. This publication is well timed in that the last few
years have seen a revival of interest in keratin profiling
studies in the differential diagnosis of carcinomas. We have,
however, frequently noted that many of the recent studies,
including this one, are duplications of studies that appeared
years ago [2]. This and the fact that a reappraisal of the
results of Carrilho et al [1] is necessary, in light of the
incorrect approach to cervical carcinogenesis, have promp-
ted our response.
The authors state that increased expression of keratins
8 and 17 and decreased expression of keratins 10 and 13 are
indicators for malignant transformation in the cervix. The
expression of these keratins is compared to a reference
epithelium. For keratin 8, endocervical columnar cells serve
as the reference, whereas for keratins 10 and 13, it is the
ectocervical squamous epithelium, and for keratin 17, the
authors correctly choose reserve cells as a reference
epithelium. Unfortunately, they go on to compare keratin
17 expression of cervical intraepithelial neoplasia (CIN) III
and cervical squamous cell carcinoma with ectocervical
squamous epithelium.
In our opinion, the choice of a reference epithelium is not
correct. It is a well-known fact that cervical squamous cell
carcinoma does not develop from endocervical epithelium,
the reference epithelium for keratin 8, and that few, if any,
cervical carcinomas will develop from ectocervical non-
keratinizing epithelium, the reference epithelium for keratins
10, 13, and 17. The choice of epithelium should have been
the reserve cells in the squamocolumnar junction. These cells
are thought to be the progenitor cells of practically all CIN
lesions and cervical carcinomas, including adenocarcinomas.
Reserve cells in the squamocolumnar junction proliferate
and develop into mature metaplastic squamous epithelium
via an intermediate state of immature squamous metaplastic
epithelium. If at some point the differentiating reserve cells
are infected with oncogenic human papillomavirus (HPV), a
major prerequisite has been fulfilled for possible transfor-
mation to CIN. Even after infection, transformation is a rare
event, and progression to cervical carcinoma is even rarer.This hierarchical relationship between the stem cell (reserve
cell) and cervical carcinoma means that the choice of
reference epithelia cannot be arbitrarily chosen.
Against this background, the results of Carrilho et al [1]
must be reconsidered. Reserve cells contain, among others,
keratins 8 and 17 but no keratins 10 and 13. In our studies, we
showed that approximately 50% of CIN III contained these
reserve cell keratins [3]. Other keratins, such as keratins 10
and 13, were found in some CIN lesions but usually only in
all the reserve cell keratins and often differentiation-related
keratins [4]. This prompted our conclusion that the presence
to develop into a cervical carcinoma, if not treated. On the
other hand, the absence of the reserve cell keratin phenotype
indicates that a CIN lesion is not progressive and will regress,
transforming into a mature squamous metaplastic epithelium.
We had legitimate reasons for this perhaps very speculative
conclusion. First, the high fidelity of keratin expression is a
well-known phenomenon. Basically, this means that the
keratins identified in a carcinoma are normally also found in
the carcinoma progenitor cell. Second, the percentage (50%)
of CIN III expressing the reserve cell keratin phenotype
approximated estimates of the fraction of CIN III with a
malignant potential.
We reported a reserve cell keratin phenotype in all cervical
carcinomas further supporting the high-fidelity rule. This
percentage is higher than that reported by Carrilho et al [1].
As they correctly state, this difference is attributable to the
fact that our initial studies were applied to fresh frozen tissue
specimens [4]. Because we realized the consequence of the
hypothesis that reserve cell keratins may well indicate the
potential of CIN III to progress to cervical carcinoma, we
repeated the studies with a comprehensive panel of keratin
antibodies on archival formalin-fixed paraffin-embedded
material. Our results of a decade ago were similar to those
of Carrilho et al [1,2].
We do agree with the authors’ conclusion that applica-
tion of keratin antibodies could be valuable in the
subclassification of cervical carcinoma, an observation we
published many years ago [2,4]. Time has not stood still for
the cervix since we preformed the studies summarized
above. It is encouraging to see that our results are
reproducible but saddening to conclude that the model for
cervical carcinogenesis is so loosely adhered to. We have
modified the position we had 12 years ago, and this
influences our interpretation also with regard to keratin
expression in the cervix. Progression rates of 50% for CIN
II/III to cervical carcinoma are exaggerated; based on
literature, 20% would seem more realistic. We furthermore
underestimated the role of HPV at the time and now think
that integration of HPV in the human genome is pivotal in
progression from CIN III to cervical carcinoma [5]. Keratin
phenotyping in relation to viral status would therefore seem
the logical step forward.
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4200-465 Porto, PortugalTo the Editor,
We thank Smedts et al for their interest in the study we
published in Human Pathology [1]. These authors
criticize our choice of ectocervical squamous epithelium as
a reference for comparative purposes on keratin staining
patterns. The criticism stems from the fact that, for example,
keratin 17 stains reserve cells, and therefore these cells
should be used as a reference. Although we agree that
strictu sensu the term breference epitheliumQ may bemisleading, we are confident the readers will understand
our rationale of comparing the keratin expression profiles of
squamous carcinomas (invasive carcinomas and cervical
intraepithelial neoplasia lesions) with those of ectocervix
epithelium. Both in cytology and in biopsy specimens, the
diagnostic problems are centered on the features of
squamous cells. It was not our aim to approach cervical
carcinogenesis using keratin markers—so we disagree that
our approach was incorrect. We simply did not approach
that issue. Regarding the actual problem we were interested
in, to evaluate the usefulness of keratin markers for
diagnostic purposes, our data conf irm those published by
the group of Smedts et al, and we have explicitly
acknowledged this fact. We think it is important to confirm
previous studies performed in several laboratories before
the conclusions are used for diagnostic purposes. In con-
clusion, the issue raised in the last paragraph of the letter
regarding comparison of keratin phenotyping in relation to
viral status has been addressed, and the results will be
published soon.
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